Intrapartum Monitoring Devices Market is witnessing robust growth with Royal Philips launching remote patient obstetrics monitoring suite to support clinicians and expectant mothers during the COVID-19 pandemic

Intrapartum Monitoring devices are a new generation of fetal monitor devices that utilize ultrasound technology to deliver continuous monitoring during labor. These highly advanced monitors do not require patients to remain in the delivery room and can easily be attached to the mother's belly just before her labor begins. The device has a probe resembling a harmless camera that is inserted into the uterus via the birth canal. As the fetus grows and stimulates contractions, the ultrasound transducer produces a picture of the developing baby and the doctor can view it on the screen. Intrapartum monitoring devices are typically useful during preterm. These devices are critical in assessing the well-being of a fetus during the labor and delivery process. Such devices can play a key role in controlling infant mortality. As per the World Health Organization (WHO), February 2018, around 15 million babies are born preterm i.e. before 37 completed weeks of gestation every year. As per the Centers for Disease Control and Prevention (CDC), around 21,000 infants died in the U.S. in 2018. Hence, such factors can contribute to growth of the intrapartum monitoring devices market. 

 

Intrapartum monitoring devices have revolutionized the way that mothers are monitored during labor. These new technologies provide a high level of accuracy that was previously impossible. The picture produced is often clearer than what would be possible with older monitoring methods and there are no recordings necessary to keep track of vital signs. Over the years, the demand for maternity care devices has increased rapidly, in both developed and emerging economies. Devices such as baby scale, fetal stethoscope, infant stethoscope, and suction apparatus are critical in evaluating the health of infant babies. Thus, such factors are augmenting growth of the intrapartum monitoring devices market.

Despite its numerous advantages, there are some major issues associated with accessibility and affordability, which remain a major challenge in the adoption of intrapartum monitoring devices. Furthermore, there are stringent regulatory policies imposed by government authorizes, which could hinder growth of the intrapartum monitoring devices market in the near future.

Recently, in June 2020, Royal Philips launched a remote patient obstetrics monitoring suite to support clinicians and expectant mothers during the COVID-19 pandemic

Doctors and nurses are just beginning to discover the many ways that Intrapartum Monitoring can benefit their patients. In the case of drug withdrawal symptoms, for instance, if a mother monitors her child's drug withdrawal symptoms before it begins, doctors can intervene earlier and provide treatment. When it comes to countries, the U.S. is exhibiting promising signs in the intrapartum monitoring devices market. This is due to the fact that there is a high preterm birth rate in the country. Furthermore, the adoption of ongoing technological advancements can augment regional market growth in the near future.